News | November 18, 2024
Richard Manning provided trial testimony that contributed to a decisive legal victory for biotech startup Inhibrx in a $460 million trade secrets case brought by I-Mab Biopharma in Delaware federal district court.
April 3, 2024
We are pleased to announce the promotion of four individuals to the role of Managing Director: Stuart Allan, Bryan D’Aguiar, Matt Farber, and Ryan Marsh.
According to Managing Director Don Harvey, “Earning the title of Managing Director is a demonstration of high-quality work, leading through challenging situations, and earning clients’ trust. It requires a commitment to developing best-in-class expertise and sharing it with our professionals so we nurture the next generation of talent. I am incredibly proud to call Stuart, Bryan, Matt, and Ryan my colleagues, and I wish them continued success.”
Learn more about our new Managing Directors.
Stuart Allan | Dubai
Stuart Allan is a qualified quantity surveyor and a RICS Accredited Expert Witness with more than 15 years of international experience in construction and engineering. He has acted as quantum expert and as lead assistant to the appointed quantum expert on complex domestic and international construction and engineering projects, including the valuation of claims for damages in several jurisdictions, as well as variations under standard and bespoke forms of contract, disruption, and acceleration. He is also experienced in final accounts, remeasurement, and quantity surveying principles. His experience has been gained across various sectors and has included projects in the United Kingdom, Republic of Ireland, United Arab Emirates, Qatar, Kuwait, Saudi Arabia, Malaysia, Algeria, and South Africa.
Bryan D’Aguiar | Washington, DC
Bryan D’Aguiar leads damages and forensic investigations engagements with his financial and valuation insights and analysis drawn from more than 20 years of worldwide experience. He has provided expert evidence on valuation and damages in several international cases and arbitrations, and he applies his analytical and institutional investing experience in emerging and frontier markets. With a deep understanding of the competitive and business environment in almost 60 countries, he conducts research and valuations across multiple sectors. He has helped institutional investors invest in these markets using various structures, and his work has won numerous awards for high returns through market-leading strategies.
Matt Farber, PhD | Dallas
Dr. Matt Farber applies his deep knowledge of microeconomic theory and data analysis techniques to antitrust, intellectual property, patent infringement, trademark infringement, trade secrets, breach of contract, and false advertising matters. He regularly works in state courts, U.S. district courts, and the International Trade Commission. He has testified in U.S. district court, and provided analyses of monopolization and attempted monopolization, lost profits and reasonable royalty damages, unjust enrichment, irreparable economic injury, domestic industry considerations, and commercial success.
Ryan Marsh, PhD | Dallas
Dr. Ryan Marsh has expertise in labor economics, applied microeconomics, and applied econometrics. He applies his expertise to various complex commercial disputes, including intellectual property, breach of contract, false advertising, and antitrust disputes. He has worked across various industries, including biopharmaceuticals, medical devices, telecommunications, consumer electronics, automobiles, and petroleum, among others. Ryan has been designated an expert on matters before state courts and U.S. district court, and he has provided testimony in a matter before U.S. district court.
Richard Manning provided trial testimony that contributed to a decisive legal victory for biotech startup Inhibrx in a $460 million trade secrets case brought by I-Mab Biopharma in Delaware federal district court.
Under Dr. Guyer’s leadership, the new Engineering & Scientific Consulting practice will provide the critical research, analysis, and investigations expertise necessary to solve the challenging science, engineering, and regulatory questions behind why products fail and the implications for stakeholders.
The US Music Industries: Jobs & Benefits — 2024 Report
Robert Stoner and Jéssica Dutra have recently published The U.S. Music Industries: Jobs & Benefits—2024 Report for the Recording Industry Association of America where we measure the music industries’ economic impact nationwide, which overall contribute $212 billion to the GDP and account for 2.5 million jobs.